Stock Upgrades Today Highlight AI Winners and Market Leaders

 TopRated
 
  TopRated
 
Follow  Message
 
 
 
TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.
 

•  28 Oct 2025
 

•   APP  
   
  +0.37%
•   ASML  
   
  -0.37%
•   AVGO  
   
  +0.37%
•   BIDU  
   
  -0.37%
•   CORZ  
   
  -1.03%

$APP AppLovin got a big nod from Deutsche Bank, which initiated coverage with a Buy rating and a $705 target. Analysts say its AI-powered advertising engine is firing on all cylinders, helping the company dominate mobile ad tech. With investors chasing AI exposure, APP blend of machine learning and marketing reach makes it a serious contender among growth names.

$ASML Holding continues to prove why it's a critical player in the semiconductor supply chain. The stock has been staging a powerful rebound lately, fueled by analyst upgrades and optimism about chip demand recovery. With the AI boom demanding more advanced lithography, ASMLfuture looks etched in bright light.

$AVGO Goldman Sachs reaffirmed its Buy rating on Broadcom, underscoring its leadership in semiconductors and infrastructure software. The integration of VMware and ongoing AI-driven chip demand could push earnings higher, solidifying AVGO status as a long-term compounder in the tech space.

$BIDU CMB International stuck with its Buy rating on Baidu, showing faith in the Chinese tech giant AI strategy. As Baidu continues to expand its generative AI ecosystem and autonomous driving efforts, the market may be underestimating its comeback potential.

$CORZ Roth upgraded Core Scientific to Buy, boosting its price target to $23.50. The firm noted that the upgrade assumes no deal with CoreWeave, signaling confidence in CORZ standalone growth prospects. With crypto mining capacity ramping up and AI infrastructure overlap rising, CORZ might be quietly positioning itself for a multi-sector run.

$CVS CVS Health is seeing momentum return to its Pharmacy and Consumer Wellness units. Analysts are bullish on its revamped CostVantage model and the integration of new Rite Aid assets. With cost efficiencies and a stronger retail health footprint, CVS could surprise in the next few quarters.

$EFX Equifax received a rating upgrade driven by improving earnings visibility. As data demand grows and credit activity stabilizes, the firm analytics and risk solutions may drive solid margin expansion in the near term.

$EZPW Canaccord Genuity reaffirmed its Buy on EZCORP, hiking the price target to $27. Strong pawn trends and disciplined cost control make EZPW a quiet outperformer in the credit services space one that benefits when consumer liquidity tightens.

$FOX Citigroup maintained its Buy rating on Fox seeing a modest upside ahead. While traditional media faces challenges, Fox focus on sports and live content continues to provide a steady stream of advertiser interest and viewership resilience.

$LINE Barclays kept its Buy on Lineage Inc. while trimming the price target slightly to $47. Despite industry headwinds, analysts remain confident in the fundamentals and market positioning, noting that operational execution remains strong.

$META Monness maintained its Buy rating on Meta Platforms, highlighting strength in its advertising engine and AI-driven personalization tools. With user engagement metrics improving and new AI features rolling out across platforms, META remains a digital juggernaut heading into 2025.

$MSFT Microsoft continues to impress analysts as both BofA and UBS reiterated Buy ratings. The focus remains on Azure growth momentum, which is showing renewed acceleration. With a $650 price target, UBS call reflects high conviction that MSFT will continue to lead in AI infrastructure and enterprise cloud.

$NDSN Nordson released its ESG update, underscoring long-term sustainability and margin initiatives. The energy efficiency investments and operational upgrades could enhance profitability and attract ESG-focused investors.

$NOW TD Cowen reaffirmed its Buy rating on ServiceNow citing durable demand for automation software. With enterprises still digitizing workflows at scale, NOW remains one of the purest plays on the cloud-driven productivity wave.

$NXT Nextracker remains a shining solar star, up over 200% since its last Buy rating. Analysts believe the renewable energy tailwind, backed by infrastructure spending, could keep NXT growth story alive for years.

$ORCL UBS reiterated its Buy on Oracle with a $380 price target after its AI World event. Analysts came away impressed by customer adoption of Oracle AI-driven database and cloud offerings, placing ORCL among the big beneficiaries of the next wave in enterprise AI.

$SNOW Snowflake stays in analysts good books as AI integration fuels new opportunities in data management. Analysts say the ability to help firms structure and leverage AI-ready data sets keeps SNOW well-positioned for growth.

$TEM Tempus AI earned a reiterated Buy rating from Canaccord Genuity with a $110 target. The firm sees enormous upside as AI adoption in healthcare accelerates. With real-world clinical applications gaining traction, TEM could emerge as a next-gen medical data leader.

$VERI Veritone was initiated with a Buy rating and a $10 target at Needham. The stock 180% rally in six months shows investor excitement around its AI audio and video solutions. Analysts believe the story has further to run as demand for generative AI tools expands.

$VIST Vista Energy popped nearly 19% after JPMorgan upgraded its rating and raised its price target. The move reflects optimism around Latin American energy production and cash flow strength as oil prices stabilize.

$VRTX Vertex Pharmaceuticals remains a Buy as analysts eye Q3 earnings catalysts. Strong demand for its cystic fibrosis treatments and expanding gene-editing pipeline could keep momentum alive into 2026.

$WBD Warner Bros. Discovery was raised to Buy at Argus on speculation of a potential bidding war. With its vast content library and improving debt outlook, the stock may finally be ready for its Hollywood comeback moment.

View All Headlines